XML 49 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Equity
 12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Equity
Note 14—Equity
Common Stock
The changes in our shares of common stock, as categorized in the equity section of the balance sheet, were:
Shares
202220212020
Issued
Beginning of year2,091,562,747 1,798,844,267 1,795,652,203 
Acquisition of Concho— 285,928,872 — 
Distributed under benefit plans9,322,387 6,789,608 3,192,064 
End of year2,100,885,134 2,091,562,747 1,798,844,267 
Held in Treasury
Beginning of year789,319,875 730,802,089 710,783,814 
Repurchase of common stock87,709,187 58,517,786 20,018,275 
End of year877,029,062 789,319,875 730,802,089 
Preferred Stock
We have authorized 500 million shares of preferred stock, par value $0.01 per share, none of which was issued or outstanding at December 31, 2022 or 2021.
Noncontrolling Interests
In 2020, we completed the divestiture of our subsidiaries that held our Australia-West assets and operations. These assets included the Darwin LNG and Bayu-Darwin Pipeline operating joint ventures in which there was a noncontrolling interest. As a result, as of December 31, 2020, we had no noncontrolling interests.
Repurchase of Common Stock
In late 2016, we initiated our current share repurchase program. In October 2022, our Board of Directors approved an increase to our authorization from $25 billion to $45 billion of our common stock to support our plan for future share repurchases. In May 2021, we began a paced monetization of our CVE common shares, the proceeds of which have been applied to share repurchases. During the first quarter of 2022, we sold our remaining 91 million CVE common shares. Share repurchases since inception of our current program totaled 335 million shares at a cost of $23 billion through the end of December 2022.